Doliracetam
Chemical compound
- none
- In general: unscheduled
- 2-(2-oxo-3-phenyl-3H-indol-1-yl)acetamide
- 84901-45-1
Y
- 208851
- 180958
N
- N70177JQTB
- ChEMBL2106519
N
- DTXSID20868846
- Interactive image
- C1=CC=C(C=C1)C2C3=CC=CC=C3N(C2=O)CC(=O)N
InChI
- InChI=1S/C16H14N2O2/c17-14(19)10-18-13-9-5-4-8-12(13)15(16(18)20)11-6-2-1-3-7-11/h1-9,15H,10H2,(H2,17,19)
N
- Key:MVZYGLQQNPFARE-UHFFFAOYSA-N
N
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Doliracetam is a nootropic drug (cognition enhancer) from the racetam family used in treatment of epilepsy.[1][2]
According to the Hoechst patent title, it has neuroanabolic action.
See also
- Piracetam
References
- ^ EP 62887, Kuch, Heinz & Kruse, Hansjörg, "Indolinone-2 derivatives, process for their preparation and neuro-anabolic mediums containing them", published 1982-10-20, assigned to Hoechst AG
- ^ Fariello RG, Ghelardini C, Di Cesare Mannelli L, Bonanno G, Pittaluga A, Milanese M, Misiano P, Farina C (June 2014). "Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain". Neuropharmacology. 81: 85–94. doi:10.1016/j.neuropharm.2014.01.029. PMID 24486381. S2CID 28039482.
- v
- t
- e
Racetams
- Aniracetam
- Brivaracetam
- Cebaracetam
- Coluracetam
- Dimiracetam
- Doliracetam
- Dupracetam
- Etiracetam/Levetiracetam
- Fasoracetam
- Imuracetam
- Methylphenylpiracetam
- MRZ-9547 ((R)-phenylpiracetam)
- Nebracetam
- Nefiracetam
- Omberacetam (Noopept)
- Oxiracetam
- Phenylpiracetam (phenyltropil; fonturacetam)
- Phenylpiracetam hydrazide
- Piracetam
- Pramiracetam
- Rolipram
- Rolziracetam
- Seletracetam
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e